Company intelligence / Profile preview

Ryse Health

Baltimore, Maryland, USArysehealth.com ↗

Ownership: Private
Employees: ~22
Development stage: Commercial

Overview

Early clinical results show a two-point drop in A1C for patients starting above an A1C of eight percent and a thirty-six percent decrease in elevated blood sugars after the first sixty days of the program. Patients report improved energy and well-being. The company claims up to fifty percent better results compared to standard approaches.

Therapeutic areas: Endocrinology
Modalities: Device (continuous glucose monitor)Non-pharmacological therapy (coaching, behavioral support)Digital health platform/app
Industry: Non-Academic Healthcare

Partnerships

LifeBridge Health

Beyond the preview

Go deeper on Ryse Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ryse Health.

Explore the full profile